Das Martin-Luther-Krankenhaus ist ein evangelisches Krankenhaus im Ortsteil Schmargendorf des Berliner Bezirks Charlottenburg-Wilmersdorf. Das Krankenhaus verfügt über 285 Betten. Es ist Akademisches Lehrkrankenhaus der Charité Universitätsmedizin Berlin.

During the past decade, Martin-Luther-Krankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Martin-Luther-Krankenhaus" #1 sponsor was "Charite University, Berlin, Germany" with 4 trials, followed by "Ethicon, Inc." with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored, "Geistlich Pharma AG" with 1 trials sponsored and "Norgine" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martin-Luther-Krankenhaus" #1 collaborator was "BARMER" with 2 trials as a collaborator, "Technische Universität Berlin" with 2 trials as a collaborator, "Fraunhofer-Institut für Offene Kommunikationssysteme FOKUS, Berlin, Germany" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA), Berlin, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Martin-Luther-Krankenhaus" are "Cartilage Disease" (1 trials), "Cartilage Injury" (1 trials), "Chronic Heart Failure" (1 trials), "Cicatrix" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "Martin-Luther-Krankenhaus" in a lesser frequency.

Most popular intervention types in "Martin-Luther-Krankenhaus" are "Behavioral" (3 trials), "Device" (3 trials), "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Prehabilitation- new form of care" (2 trials), "1R, 2S-methoxamine hydrochloride" (1 trials), "ICU Usual Care" (1 trials), "Juvista (avotermin)" (1 trials) and "Microfracture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martin-Luther-Krankenhaus" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Martin-Luther-Krankenhaus". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Martin-Luther-Krankenhaus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Martin-Luther-Krankenhaus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".